Today for AI
HOT RADAR
industryHEAT 19.5°

AI CURATED HOT STORY · 11/13/2026

Chinese Medical LLM MedGPT Tops 250 Doctors in Lung Cancer Study

2 reports archived2 independent sourcesupdated 11/13/2026, 15:43:03
Synthesis & Latest Updates
2 Sources Cross-Validated

Chinese medical AI company Future Doctor's MedGPT model outperformed 250 tertiary-hospital physicians by 88 to 12 in a 40-case complex lung cancer evaluation, and boosted physician scores by 24.1% in human-AI collaboration. The study also showed MedGPT outperforming general models including GPT-5.4, Claude Opus 4.7 and Gemini 3.1 Pro, drawing endorsements from leading Chinese and U.S. oncologists.

LATEST/Chinese medical AI company Future Doctor's MedGPT model outperformed 250 tertiary-hospital physicians by 88 to 12 in a 40-case complex lung cancer evaluation, and boosted physician scores by 24.1% in human-AI collaboration. The study also showed MedGPT outperforming general models including GPT-5.4, Claude Opus 4.7 and Gemini 3.1 Pro, drawing endorsements from leading Chinese and U.S. oncologists.

Hourly heat curve

13 fully observed hours
Now
19.5
Peak
22.616:00
24h change
–

The line compares only sources observed throughout; gap hours are interpolated to keep the trend continuous.

Coverage timeline

Total 2 reports · Latest first
  1. 量子位官网T2·62 pts

    Chinese Medical LLM MedGPT Tops 250 Doctors in Lung Cancer Study

    • MedGPT beat 250 tertiary-hospital physicians 88 to 12 across 40 complex lung cancer cases, lifting physician scores by 24.1% in collaboration
    • MedGPT outperformed general models such as GPT-5.4, Claude Opus 4.7 and Gemini 3.1 Pro in complex clinical decision-making
    • Endorsed by Chinese Medical Association committee-level experts and top U.S. oncologists from UCSF and City of Hope for clinical utility